Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma

Rapamycin, a mammalian target of rapamycin (mTOR) signaling inhibitor, inhibits cancer cell proliferation and tumor formation, including in nasopharyngeal carcinoma (NPC), which we proved in a previous study. However, whether rapamycin affects cancer stem cells (CSCs) is unclear. In examining sample...

Descripción completa

Detalles Bibliográficos
Autores principales: YANG, CHUNGUANG, ZHANG, YUE, ZHANG, YU, ZHANG, ZIHENG, PENG, JIANHUA, LI, ZHI, HAN, LIANG, YOU, QUANJIE, CHEN, XIAOYU, RAO, XINGWANG, ZHU, YI, LIAO, ZHISU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532219/
https://www.ncbi.nlm.nih.gov/pubmed/26202311
http://dx.doi.org/10.3892/ijo.2015.3100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532219/
https://www.ncbi.nlm.nih.gov/pubmed/26202311
http://dx.doi.org/10.3892/ijo.2015.3100

Ejemplares similares